In the same study, HAVCR2 was found to have a prognostic role in CESC, KIRC, SKCM, and osteosarcoma, and an adverse role in the prognosis of GBM, GBMLGG, LGG, PRAD, and UVM. The gene discussed is HAVCR2; the disease is glioblastoma.